Drug Reports from Cortellis for Competitive Intelligence
Thomson Reuters Cortellis for Competitive Intelligence is an intuitive intelligence tool with access to a huge database of drug pipelines, deals, patents, companies, and the latest industry news. Learn more by previewing sample drug reports and sign-up for a free two week trial.
Over 40,000 drug reports are available in Thomson Reuters Cortellis for Competitive Intelligence, such as Erlotinib (Tarceva), Etanercept (Enbrel), Imatinib (Gleevec), Infliximab (Remicade) and Pregabalin (Lyrica).